UNITY DX Cornea Study
Condition(s) studied
Investigational drug(s) / intervention(s)
UNITY DX: Investigational non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties
ANTERION: Commercially available non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties
Study summary
The purpose of this study is to validate the clinical measurement performance of an investigational biometer. Subjects will undergo multiple measurements of the eye, and the agreement, repeatability, and reproducibility of corneal and epithelial thickness maps will be evaluated.
Eligibility
Primary outcome measure(s)
- Mean corneal thickness — Day 1
Corneal thickness will be measured by the device and reported in microns. This outcome measure will be analyzed using Bland-Altman Limits of Agreement, Deming regression, repeatability and reproducibility. - Mean epithelial thickness — Day 1
Epithelial thickness will be measured by the device and reported in microns. This outcome measure will be analyzed using Bland-Altman Limits of Agreement, Deming regression, repeatability and reproducibility.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| The Eye Institute of Utah | Salt Lake City | Utah | Recruiting |
More Alcon Research trials in the USA
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07768735 on ClinicalTrials.gov ↗ ← All trials in the USA